Know Cancer

or
forgot password

Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients


Phase 2
18 Years
N/A
Open (Enrolling)
Both
Xerostomia

Thank you

Trial Information

Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients


10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for
severity of xerostomia using questionnares and quantitative salivation tests. patients
responsive to citric acid will receive a hypnotic session with specific suggestion for
salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD
with recorded hypnotic session to use freely at home. xerostomia will be assessed using a
questionnare one week following hypnosis.


Inclusion Criteria:



- radiotherapy for head and neck cancer

- xerostomia

Exclusion Criteria:

- psychiatric illness (present or past)

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

salivaa volume

Principal Investigator

Elad Schiff

Investigator Role:

Principal Investigator

Investigator Affiliation:

Bnai Zion MC

Authority:

Israel: Ministry of Health

Study ID:

eschiff

NCT ID:

NCT00408759

Start Date:

November 2006

Completion Date:

December 2006

Related Keywords:

  • Xerostomia
  • xerostomia
  • hypnosis
  • dry mouth
  • radiotherapy
  • head and neck cancer
  • Xerostomia
  • Head and Neck Neoplasms

Name

Location